Technology
Health
Medical

NuVasive

$61.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.49 (0.80%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell NuVasive and other stocks, options, ETFs, and crypto commission-free!

About

NuVasive, Inc. engages in the development of minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. It offers cervical and spine fusion surgery, cervical plating, and posterior fixation products. Read More The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA.

Employees
2,600
Headquarters
San Diego, California
Founded
1997
Market Cap
3.19B
Price-Earnings Ratio
66.10
Dividend Yield
0.00
Average Volume
651.94K
High Today
$61.61
Low Today
$60.83
Open Price
$61.07
Volume
196.79K
52 Week High
$72.41
52 Week Low
$43.51

Collections

Technology
Health
Medical
US
North America

News

Yahoo FinanceMay 14

VREX vs. NUVA: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Products sector have probably already heard of VAREX IMAGING (VREX) and NuVasive (NUVA). But which of these two companies is the best option for those looking for undervalued stocks?

26
TradingNewsNowMay 8

Long or Short: NuVasive (NASDAQ: NUVA)

NuVasive is part of the healthcare sector and medical devices industry. The company CEO is James Christopher Barry. NuVasive Inc is a medical device company. It develops minimally-disruptive surgical products and procedurally-integrated solutions for the spine. Its product portfolio is focused on applications for spine fusion surgery. Previous Intraday Trading Performance: The NUVA stock showed a previous change of -4.05% with an open at 64.73 and a close of 62.82. It reached an intraday high of 65.11 and...

26
Yahoo FinanceMay 7

See what the IHS Markit Score report has to say about NuVasive Inc.

NuVasive Inc NASDAQ/NGS:NUVA View full report here! Summary ETFs holding this stock are seeing positive inflows but are weakening Bearish sentiment is moderate and increasing Economic output in this company's sector is expanding Bearish sentiment Short interest | Neutral Short interest is moderate for NUVA with between 5 and 10% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short posit...

1

Earnings

$0.39
$0.49
$0.59
$0.69
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 30, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.